IBC Minutes, June 11, 2025
VA Greater Los Angeles Healthcare System Research and Development Committee Institutional Biosafety Committee
Minutes, June 11, 2025
VA Greater Los Angeles Healthcare System—691, Teams Meeting
Members Present
Yasutada Akiba, MD, PhD, Chair (Voting)
Noor M. Alam, PhD, Co-Vice Chair (Voting)
Muhammad T. Bashir, MD, Co-Vice Chair (Voting)
Ella Bronstein, Community Representative (Voting)
Noah Gross, PhD, Research Biosafety Officer (RBSO) (Ex-Officio, Voting)
Kostyantyn Krysan, PhD, Research Scientist (Voting)
James Matsunaga, PhD, Research Scientist (Voting)
Agnes K. Nagy, PhD, Research Scientist (Voting)
Xiaoyan Ren, MD, PhD, Research Scientist (Voting)
Members Absent
Yuxin E. Li, MD, PhD, Research Scientist/Clinician (Voting)
Erika Miller, Community Representative (Voting)
Mark Sitek, MS, Radiation Safety Officer (Ex-Officio, Voting)
Ben Spivey, Chief, Safety & Emergency Management (Ex-Officio, Voting)
Alternate Members Absent
Bischoff, David, PhD, Voting Alternate for Noah Gross
Natalie Farnham, Industrial Hygiene, Voting Alternate for Ben Spivey
Jasvinder Singh, Voting Alternate for Ben Spivey
Non-Members Present
John Berard, PhD, SRS Coordinator
Fredricka C. Martin, PhD, Animal Program Compliance Officer (APCO)
David Oh, MD, RCO
Margaret A. Roch, BS, AA
I. Call To Order: Dr. Akiba called the meeting to order on June 11, 2025, at 1:02 p.m. There were 8 voting members present, meeting the quorum requirement of 7.
II. Announcements
III. Minutes
IV. New Business
A. Review of New Projects
IRBNet ID 1883625-1
PI: Golshani, Peyman, M.D., PhD.
Study Title: Dysfunctional neural dynamics of dentate gyrus granule cells in temporal lobe epilepsy
Issues Requiring Modifications and/or Corrections: The Committee determined that the following contingencies and comments be forwarded to the PI, who must provide a satisfactory response to each before final approval can be considered.
Item 1: Training Assurance Form. Check the “Physical hazards” box.
Item 2: PSP, Table A3. Check the” Hazardous drugs/Chemicals” box.
Item 3: PSP, Table B. For histology at the VA campus, which sections and immunostaining methods will be used, paraffin or cryostat, HRP histochemistry or immunofluorescence? Please add other chemicals if used for paraffin sections (ethanol, xylene, etc.) or HRP staining (H2O2, DAB, etc.) or nuclear staining (DAPI, etc.) to the table.
Item 4: PSP, Section H. Table D1 lists two viral vectors: AAV-DIO-GCAMP8f and AAV-DIO-HMDI. Please complete Table H for both vectors.
Motion: Moved and seconded to require modifications for approval of this submission. 8 yes, 0 no, 0 abstentions, 0 recusal. Motion Carried
B. Review of Amendments/Modifications
Dr. Matsunaga joined the meeting. There were 9 voting members present.
Drs. Alam and Bashir recused themselves from the discussion and votes on the following submission. There were 7 voting members present at the time of the vote.
IRBNet ID 1836306-2
PI: Alam, Noor, PhD
Study Title: Preoptic/Hypothalamic Mechanisms Of Sleep-Wake Regulation (2025)
Issues Requiring Modifications and/or Corrections: The Committee determined that the following contingencies and comments be forwarded to the PI, who must provide a satisfactory response to each before final approval can be considered.
Item 1: Chemical Inventory. Add and highlight Bupivacaine to the chemical inventory. Contact David.Bischoff@va.govto get the most recent copy of the chemical inventory.
Motion: Moved and seconded to require modifications for approval of this submission. 7 yes, 0 no, 0 abstentions, 2 recusals. Motion Carried
Drs. Alam and Bashir returned to the meeting following the vote. There were 9 voting members present.
Dr. Matsunaga left the meeting. There were 8 voting members present.
C. Review of Triennials
D. Review of Continuation Reviews:
IRBNet ID 1616023-9
PI: Kremen, Thomas, MD
Study Title: Targeting Molecules to the Enthesis via Novel Bisphosphonate Chaperones and Biomimetic Scaffolds
Primary Reviewer: Kostyantyn Krysan, PhD
Issues Requiring Modifications and/or Corrections: The Committee determined that the following contingencies and comments be forwarded to the PI, who must provide a satisfactory response to each before final approval can be considered.
Item 1: PSP, Part B3. Uncheck the "Yes" box in Part B3 as the instructions state to skip to part B5 if the chemicals will only be used outside the VA.
Item 2: PSP, Table B. Add "at UCLA only" to each of the chemicals in the able as they will only be used at UCLA.
Item 3: PSP, Part E1. Check the “Yes” box.
Item 4: PSP, Part F1. Both boxes are checked. Part A3 indicates animals will be used and the previous PSP stated rat limb tissue will be used. If animal specimens, tissues, or cells will be used, uncheck the “No” box and complete Table F. If not, check the “No” box in Part A3 and uncheck the “Yes” box in Part F1.
Item 5: PSP, Part H3. Check the “Yes” box.
Item 6: PSP, Table H3. Complete Table H3 because H2 indicates you will be treating cell cultures with other replication incompetent viral vectors
Item 7: PSP, Part L1. Check the “No” box.
Motion: Moved and seconded to require modifications for approval of this submission. 8 yes, 0 no, 0 abstentions, 0 recusal. Motion Carried
IRBNet ID 1626640-9
PI: Pisegna, Joseph R., MD
Study Title: Gastrointestinal neuropeptides regulation of appetite, metabolism, obesity, fatty liver and Non Alcoholic Steatohepatitis (NASH)
Issues Requiring Modifications and/or Corrections: None
Motion: Moved and seconded to approve this submission. 8 yes, 0 no, 0 abstentions, 0 recusal. Motion Carried
V. Unfinished Business
A. Final Approvals
1. Modifications
2. Triennials
3. Annual Continuations and PSPs
IRBNet ID 1616121-6
PI: Bischoff, David, PhD
Study Title: Role of Angiogenic CXC Chemokines in Intramembranous Bone Repair
PSP
B. Previously Approved Pending with Response Received and Under Review:
IRBNet ID 1657182-6
PI: Marcus, Elizabeth, MD
Study Title: The role of CagA/CagPAI in H. pylori-induced decrease in Na, K-ATPase as a mechanism of gastric injury
PSP
IRBNet ID 1616151-13
PI: Tsukamoto, Hidekazu, DVM, PhD
Study Title: Mitochondrial Dysfunction, Permeability Transition Pore, and Acute Pancreatitis
C. Previously Tabled Submissions For Which A Response Has Been Received.
D. Previously Reviewed Submissions For Which No Response Has Been Received.
IRBNet ID 1739101-2
PI: Benhammou, Jihane
Study Title: A lipid signaling network through stearoyl Co-A desaturase regulates hepatocellular carcinogenesis through YAP/TAZ activity
XI. Adjournment: The meeting was adjourned at 2:20 p.m. The next meeting is scheduled for July 9, 2025, at 1:00 p.m. via Teams.